Michigan Pain Management v. Progressive Marathon Insurance Co

CourtMichigan Court of Appeals
DecidedJanuary 16, 2026
Docket373896
StatusUnpublished

This text of Michigan Pain Management v. Progressive Marathon Insurance Co (Michigan Pain Management v. Progressive Marathon Insurance Co) is published on Counsel Stack Legal Research, covering Michigan Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Michigan Pain Management v. Progressive Marathon Insurance Co, (Mich. Ct. App. 2026).

Opinion

If this opinion indicates that it is “FOR PUBLICATION,” it is subject to revision until final publication in the Michigan Appeals Reports.

STATE OF MICHIGAN

COURT OF APPEALS

MICHIGAN PAIN MANAGEMENT, LLC, and UNPUBLISHED LABORATORY SPECIALISTS OF MICHIGAN, January 16, 2026 LLC, 10:07 AM

Plaintiffs-Appellants,

v No. 373896 Oakland Circuit Court PROGRESSIVE MARATHON INSURANCE LC No. 2024-206468-NF COMPANY and PROGRESSIVE MICHIGAN INSURANCE COMPANY,

Defendants-Appellees.

Before: RIORDAN, P.J., and MURRAY and MALDONADO, JJ.

PER CURIAM.

In this insurance coverage dispute involving personal injury protection (“PIP”) benefits under the no-fault act, MCL 500.3101 et seq., plaintiffs, Michigan Pain Management, LLC (MPM), and Laboratory Specialists of Michigan, LLC, appeal as of right the opinion and order granting summary disposition under MCR 2.116(C)(10) (no genuine issue of material fact) to defendants, Progressive Marathon Insurance Company and Progressive Michigan Insurance Company (collectively, Progressive), and determining plaintiffs were not entitled to PIP benefits because the underlying claimant, Stacie Washington, lacked coverage on the date of the subject automobile accident. Plaintiffs challenge the earlier opinion and order granting partial summary disposition under MCR 2.116(C)(10) to Progressive, dismissing MPM’s claims for treatment because it was not reasonably necessary for Washington’s care. We affirm.

I. BACKGROUND

This matter stems from injuries sustained by Washington in a July 6, 2023 motor vehicle accident and her treatment by two medical providers. Before the accident, Washington obtained an automobile insurance policy for PIP benefits with Progressive, which was to be effective from April 5, 2023 until October 5, 2023. When Washington signed up for the policy, she saved a debit card to her account for future payments. Washington paid the first two monthly premiums.

-1- However, the next payment was declined on June 5, 2023. A cancellation notice was mailed to Washington on June 9, 2023, indicating that the policy would be cancelled at 12:01 a.m. on June 22, 2023, for nonpayment of a premium unless a payment of $217.36 was made by June 22, 2023. Washington testified she did not know she missed a payment, did not receive a cancellation notice, and did not believe her policy was cancelled. Janeen Copic, an insurance litigation representative at Progressive, averred Washington did not pay the overdue premium and the policy was cancelled at 12:01 a.m. on June 22, 2023. A transaction history log indicated a “[f]inal [c]ancel” was entered on June 23, 2023.

On July 6, 2023, Washington was involved in an automobile accident as a passenger and sustained injuries to her back, shoulder, ribs, and neck. A final bill was mailed to Washington on July 13, 2023, stating Washington lost coverage on June 22, 2023. Washington testified she did not receive the final bill. On July 13 and 14, 2023, Washington accessed her Progressive account online. At 12:40 a.m. on July 14, 2023, Washington electronically signed a statement of no loss, in which she verified four statements. In three of the statements, Washington verified that, between 12:01 a.m. on June 22, 2023 and the date and time she signed the document, there was “no damage to or theft of any of the vehicles,” no household member was “involved in any motor vehicle accidents,” and “no one operating a vehicle listed on [the] policy has been involved in an accident.” Washington verified “that, if [the] policy is reinstated, Progressive will not cover any accidents or damages between June 22, 2023 and the date and time [Washington] signed this document.” Washington testified she never signed the statement of no loss nor made a payment on July 14, 2023. Copic averred Washington’s policy was reinstated at about 12:42 a.m. on July 14, 2023, after the premium was paid. The transaction history log and customer interaction history logs showed a payment of $217.36 and a “[r]einstatement” on July 14, 2023.

After the accident, Washington was treated by Mustafa Shukr, M.D., and his assistant, Tarick Salamey, for low back pain at MPM. MPM’s treatment included a neurostimulation device (also known as “the Soleve”) produced by Nervomatrix that measures skin impedance using trigger point impedance imaging (TPII) to target myofascial trigger points and provide transcutaneous electrical nerve stimulation (TENS) treatment (hereinafter, “the treatment” or “the Nervomatrix machine”). The treatment is intended “for back pain relief” and patients with trigger points. Washington received four treatments between November 2023 and January 2024. Each treatment lasted 10 to 15 minutes and involved different amounts of “treatment points.” Washington stated the treatment “locate[d]” nerve damage in her back and pinched or shocked the nerve to alleviate pain. A technician at Michigan Management calibrated the frequency on the Nervomatrix machine and sent the results to Dr. Shukr. Washington stated it was “hard” to discern whether the treatment helped and ceased the treatment because of her epilepsy. Washington received urine drug testing at Laboratory Specialists on eight separate occasions after the accident. On February 15, 2024, Washington assigned her rights to enforce the payment of charges incurred for medical treatment to plaintiffs.

Plaintiffs filed a complaint seeking PIP benefits. MPM claimed $64,127 in medical expenses and Laboratory Specialists claimed $12,357.10 in medical expenses. Progressive filed four dispositive motions, two of which the trial court ruled on and are subject to this appeal.

Progressive moved for partial summary disposition under MCR 2.116(C)(10) regarding the lack of efficacy of the Nervomatrix treatments provided by MPM to Washington to treat alleged

-2- back pain caused by the accident. Progressive argued the Nervomatrix treatments were not reimbursable under MCL 500.3107 because there was no objective medical proof of its efficacy under Krohn v Home-Owners Ins Co, 490 Mich 145; 802 NW2d 281 (2011). Instead, Progressive contended the treatments were experimental and not reasonably necessary for Washington’s care, recovery, or rehabilitation, as Dr. Shukr’s testimony failed to show the treatment was anything more than a placebo, and scientific studies regarding the treatment were insufficient to establish even a genuine issue of fact regarding efficacy. Plaintiffs opposed the motion, arguing that, although the treatment was new, there was a genuine issue of fact regarding its objective efficacy. Plaintiffs asserted the treatment was approved by the United States Food and Drug Administration (FDA), and several articles and studies supported the treatment was efficacious.

Having dispensed with oral argument, the trial court issued an opinion and order granting the motion for partial summary disposition. The trial court stated plaintiffs did not meet the burden of proving that “the device is efficacious in its intended use to treat back pain caused by a motor vehicle accident” under Krohn. The trial court noted any testimony from Dr. Shukr was inadmissible under MRE 702. The trial court concluded:

. . . Progressive has presented evidence, in the form of a medical journal article summarizing a study funded by the device’s manufacturer, to establish that Nervomatrix is no better than a placebo for treatment of lower back pain. [MPM] has not presented evidence to establish that the Nervomatrix treatment was reasonably necessary for Ms. Washington’s care, recovery, or rehabilitation as required by MCL 500.3107(l)(a) as interpreted by the Supreme Court in Krohn. . . .

The Krohn Court concluded that whether a service is reasonably necessary must be determined under an objective standard. 490 Mich at 159-160. [Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Medtronic, Inc. v. Lohr
518 U.S. 470 (Supreme Court, 1996)
Kevin Krohn v. Home-Owners Ins Co
802 N.W.2d 281 (Michigan Supreme Court, 2011)
O’neal v. St John Hospital & Medical Center
791 N.W.2d 853 (Michigan Supreme Court, 2010)
Terrien v. Zwit
648 N.W.2d 602 (Michigan Supreme Court, 2002)
Nowell v. Titan Insurance
648 N.W.2d 157 (Michigan Supreme Court, 2002)
Maiden v. Rozwood
597 N.W.2d 817 (Michigan Supreme Court, 1999)
Karbel v. Comerica Bank
635 N.W.2d 69 (Michigan Court of Appeals, 2001)
Yerkovich v. AAA
610 N.W.2d 542 (Michigan Supreme Court, 2000)
Quinto v. Cross and Peters Co.
547 N.W.2d 314 (Michigan Supreme Court, 1996)
Mettler Walloon, LLC v. Melrose Township
761 N.W.2d 293 (Michigan Court of Appeals, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Michigan Pain Management v. Progressive Marathon Insurance Co, Counsel Stack Legal Research, https://law.counselstack.com/opinion/michigan-pain-management-v-progressive-marathon-insurance-co-michctapp-2026.